Annual report pursuant to Section 13 and 15(d)

Statements of Shareholders'/Members' Equity Statements of Shareholders/Members' Equity

v2.4.0.6
Statements of Shareholders'/Members' Equity Statements of Shareholders/Members' Equity (USD $)
In Thousands, except Share data
Total
Predecessor [Member]
USD ($)
Predecessor [Member]
Retained Earnings [Member]
USD ($)
Predecessor [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
USD ($)
Predecessor [Member]
Capital Units [Member]
USD ($)
Predecessor [Member]
Common Stock [Member]
Successor [Member]
USD ($)
Successor [Member]
Retained Earnings [Member]
USD ($)
Successor [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
USD ($)
Successor [Member]
Capital Units [Member]
Successor [Member]
Common Stock [Member]
USD ($)
Balance, beginning of period at Mar. 31, 2010   $ 55,074 $ 16,513 $ 1,060 $ 37,501            
Capital units outstanding, beginning of period at Mar. 31, 2010         52,253,000            
Common stock, shares outstanding, beginning of period at Mar. 31, 2010           0          
Net income (loss)   (267) (267)                
Foreign currency translation adjustment   (576)   (576)              
Foreign curency translation adjustment   (576)                  
Foreign provision (benefit)   (177)                  
Balance, end of period at Apr. 30, 2010   54,231 16,246 484 37,501            
Capital units outstanding, end of period at Apr. 30, 2010         52,253,000            
Common stock, shares outstanding, end of period at Apr. 30, 2010           0          
Net income (loss)             (14,940) (14,940)      
Issuance of common stock for cash, shares                     21,658,530,000
Issuance of common stock for cash             112,536       112,536
Exchange of certain units of Thermon Holdings, LLC, shares                     2,825,293,000
Exchange of certain units of Thermon Holdings, LLC             14,680       14,680
Issuance of common stock for cash to certain members of management, shares                     391,846,000
Issuance of common stock for cash to certain members of management             2,036       2,036
Issuance of common stock in lieu of compensation, shares                     9,623,000
Issuance of common stock in lieu of compensation             50       50
Stock-based compensation expense             1,889       1,889
Issuance of common stock for cash to directors, shares                     48,115,000
Issuance of common stock for cash to directors             250       250
Foreign curency translation adjustment             10,031   10,031    
Foreign provision (benefit)             9,394   197    
Balance, end of period at Mar. 31, 2011             126,532 (14,940) 10,031   131,441
Capital units outstanding, end of period at Mar. 31, 2011                   0  
Common stock, shares outstanding, end of period at Mar. 31, 2011                     24,933,407,000
Net income (loss)             12,030 12,030      
Issuance of common stock for cash, shares                     4,575,098,000
Issuance of common stock for cash             48,459       48,459
Stock-based compensation expense             6,514       6,514
Foreign curency translation adjustment             (6,517)   (6,517)    
Foreign provision (benefit)             12,551   135    
Other             (152)   (152)    
Issuance of common stock in exercise of stock options, shares                     683,443,000
Issuance of common stock in exercise of stock options             3,433       3,433
Issuance of restricted stock as deferred compensation to employees and directors                     16,136,000
Excess tax deduction from stock options exercises             2,181       2,181
Balance, end of period at Mar. 31, 2012             192,480 (2,910) 3,362   192,028
Capital units outstanding, end of period at Mar. 31, 2012                   0  
Common stock, shares outstanding, end of period at Mar. 31, 2012                     30,208,084,000
Net income (loss)             26,974 26,974      
Stock-based compensation expense             1,341       1,341
Foreign curency translation adjustment             (4,133)   (4,133)    
Foreign provision (benefit)             12,352        
Other             (304)   (304)    
Issuance of common stock in exercise of stock options, shares                     1,086,486,000
Issuance of common stock in exercise of stock options             5,558       5,558
Issuance of restricted stock as deferred compensation to employees and directors                     13,012,000
Excess tax deduction from stock options exercises             4,131       4,131
Balance, end of period at Mar. 31, 2013             $ 226,047 $ 24,064 $ (1,075)   $ 203,058
Capital units outstanding, end of period at Mar. 31, 2013                   0  
Common stock, shares outstanding, end of period at Mar. 31, 2013                     31,307,582,000